David H. Miller

62.4k citations

389 papers · 39.9k indexed · 12 hit papers · h-index 104

Pathology and Forensic Medicine top 0.01%
Neurology top 0.02%
Radiology, Nuclear Medicine and Imaging top 0.02%
Rheumatology top 0.02%
Molecular Biology top 1%

Co-authors: Alan J. Thompson Gareth J. Barker W. I. McDonald Olga Ciccarelli Frederik Barkhof Daniel R. Altmann Claudia A. M. Gandini Wheeler‐Kingshott Paul S. Tofts
Topics: Multiple Sclerosis Research Studies (322 papers)Peripheral Neuropathies and Disorders (77 papers)Systemic Lupus Erythematosus Research (69 papers)
Cited by: Pathology and Forensic Medicine Neurology Rheumatology
Journals: New England Journal of Medicine The Lancet Journal of Neuroscience
Partner nations: United Kingdom Italy Netherlands

In The Last Decade

David H. Miller

389 papers receiving 38.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

2006 2.4k citations Chris H. Polman, David H. Miller et al. profile →
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

2012 1.0k citations David H. Miller et al. profile →
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

2003 936 citations David H. Miller, Katherine Miszkiel et al. profile →
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

2008 649 citations Leonora Fisniku, P A Brex et al. Brain profile →
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

2002 631 citations Olga Ciccarelli, Alan J. Thompson et al. profile →
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

2004 608 citations Daniel R. Altmann, Gareth J. Barker et al. Annals of Neurology profile →
The peripheral benzodiazepine binding site in the brain in multiple sclerosis

2000 546 citations David H. Miller et al. Brain profile →
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

2012 457 citations Madhan Kolappan, Daniel R. Altmann et al. profile →
Diagnosis of multiple sclerosis: progress and challenges

2016 447 citations Franz Fazekas, David H. Miller et al. profile →
Optic neuritis

2013 407 citations Deborah Mason, David H. Miller et al. profile →
Association between pathological and MRI findings in multiple sclerosis

2012 377 citations Massimo Filippi, Frederik Barkhof et al. profile →
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

2016 335 citations David H. Miller, Mark S. Freedman et al. profile →

Peers

Countries citing papers authored by David H. Miller

Since Specialization

Citations

This map shows the geographic impact of David H. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Miller more than expected).

Fields of papers citing papers by David H. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Miller. The network helps show where David H. Miller may publish in the future.

Co-authorship network of co-authors of David H. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Miller. A scholar is included among the top collaborators of David H. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Miller. David H. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional Connectivity Alterations Reveal Complex Mechanisms Based on Clinical and Radiological Status in Mild Relapsing Remitting Multiple Sclerosis 2018 ·Frontiers in Neurology ·Gloria Castellazzi,Laëtitia Debernard,Tracy R. Melzer,John C. Dalrymple‐Alford,Egidio D’Angelo,David H. Miller,Claudia A. M. Gandini Wheeler‐Kingshott,Deborah Mason	26
2	Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T 2016 ·PLoS ONE ·Marios Yiannakas,Francesco Grussu,(unknown),Ferrán Prados,Rebecca S. Samson,Marco Battiston,Daniel R. Altmann,Sébastien Ourselin,David H. Miller,Claudia A. M. Gandini Wheeler‐Kingshott	11
3	Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis 2015 ·NeuroImage Clinical ·Marios Yiannakas,Ahmed M. Mustafa,Benjamin De Leener,Hugh Kearney,Carmen Tur,Daniel R. Altmann,Floriana De Angelis,Domenico Plantone,Olga Ciccarelli,David H. Miller,Julien Cohen‐Adad,Claudia A. M. Gandini Wheeler‐Kingshott	51
4	Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis 2015 ·Brain ·Niamh Cawley,Bhavana Solanky,Nils Muhlert,Carmen Tur,Richard A.E. Edden,Claudia A. M. Gandini Wheeler‐Kingshott,David H. Miller,Alan J. Thompson,Olga Ciccarelli	88
5	Predicting outcome in clinically isolated syndrome using machine learning 2014 ·NeuroImage Clinical ·Viktor Wottschel,Daniel C. Alexander,(unknown),Declan Chard,ML Stromillo,Nicola De Stefano,Alan J. Thompson,David H. Miller,Olga Ciccarelli	54
6	Sodium accumulation is associated with disability and a progressive course in multiple sclerosis 2013 ·Brain ·David Paling,Bhavana Solanky,Frank Riemer,Daniel J. Tozer,Claudia A. M. Gandini Wheeler‐Kingshott,Raju Kapoor,Xavier Golay,David H. Miller	99
7	Corpus callosum damage predicts disability progression and cognitive dysfunction in primary‐progressive MS after five years 2012 ·Human Brain Mapping ·Benedetta Bodini,Mara Cercignani,Zhaleh Khaleeli,David H. Miller,María A. Ron,(unknown),Alan J. Thompson,Olga Ciccarelli	44
8	Early factors associated with axonal loss after optic neuritis 2011 ·Annals of Neurology ·Andrew Henderson,Daniel R. Altmann,S. Anand Trip,Katherine Miszkiel,Patricio G. Schlottmann,(unknown),David F. Garway‐Heath,Gordon T. Plant,David H. Miller	39
9	A method for measuring the cross sectional area of the anterior portion of the optic nerve in vivo using a fast 3D MRI sequence 2010 ·Journal of Magnetic Resonance Imaging ·Marios Yiannakas,Claudia A. M. Gandini Wheeler‐Kingshott,(unknown),Karyn E. Chappell,Andrew Henderson,Madhan Kolappan,David H. Miller,Daniel J. Tozer	12
10	Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis 2009 ·Journal of Neurology ·Thomas Hayton,J Furby,Kenneth J. Smith,Daniel R. Altmann,Robert Brenner,Jeremy Chataway,R. A. C. Hughes,Keith D. Hunter,David J. Tozer,David H. Miller,Ravish Kapoor	23
11	MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome 2009 ·BMC Neurology ·(unknown),Christoph Pohl,Chris H. Polman,Frederik Barkhof,Mark S. Freedman,Gilles Edan,David H. Miller,Lars Bauer,Rupert Sandbrink,Ludwig Kappos,Bernard M.J. Uitdehaag	16
12	Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosisbreakdown → 2008 ·Brain ·Leonora Fisniku,P A Brex,Daniel R. Altmann,Katherine Miszkiel,(unknown),Richard I. Lanyon,Alan J. Thompson,David H. Miller	649
13	Investigation of white matter pathology in ALS and PLS using tract‐based spatial statistics 2008 ·Human Brain Mapping ·Olga Ciccarelli,Timothy E.J. Behrens,Heidi Johansen‐Berg,Kevin Talbot,Richard W. Orrell,Robin Howard,Rita G. Nunes,David H. Miller,Paul M. Matthews,Alan J. Thompson,Stephen M. Smith	118
14	Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging 2008 ·Journal of Neurology ·Waqar Rashid,Andreas Hadjiprocopis,G. Davies,(unknown),Declan Chard,(unknown),Dan Altmann,Claudia A. M. Gandini Wheeler‐Kingshott,(unknown),Alan J. Thompson,David H. Miller	25
15	Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis 2004 ·Annals of Neurology ·David H. Miller,Massimo Filippi,Franz Fazekas,Jette Lautrup Frederiksen,Paul M. Matthews,Xavier Montalbán,Chris H. Polman	62
16	The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis 2002 ·Journal of Neurology ·Colette Griffin,Declan Chard,Geoff J.M. Parker,Gareth J. Barker,Alan J. Thompson,David H. Miller	65
17	Continuing optic nerve atrophy following optic neuritis: a serial MRI study 2002 ·Multiple Sclerosis Journal ·Simon J. Hickman,(unknown),P A Brex,David MacManus,Neil Scolding,D. A. S. Compston,David H. Miller	74
18	IMAGING OF THE SPINE IN MULTIPLE SCLEROSIS 2000 ·Neuroimaging Clinics of North America ·Simon J. Hickman,David H. Miller	10
19	In vivo 1 H-magnetic resonance spectroscopy of the spinal cord in humans 2000 ·Neuroradiology ·Beatriz Gómez‐Ansón,David MacManus,Geoff J.M. Parker,C. A. Davie,Gareth J. Barker,I. F. Moseley,W. I. McDonald,David H. Miller	36
20	Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance 1996 ·Magnetic Resonance in Medicine ·Mark A. Horsfield,Ming Lai,(unknown),Gareth J. Barker,Paul S. Tofts,Robert C. Turner,Peter Rudge,David H. Miller	151

About David H. Miller

David H. Miller is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology, having authored 389 papers that have together received 39.9k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (322 papers), Peripheral Neuropathies and Disorders (77 papers) and Systemic Lupus Erythematosus Research (69 papers). The work is most often cited by research in Pathology and Forensic Medicine (28.5k citations), Neurology (11.1k citations) and Rheumatology (8.2k citations). David H. Miller has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Alan J. Thompson, Gareth J. Barker, W. I. McDonald, Olga Ciccarelli, Frederik Barkhof, Daniel R. Altmann, Claudia A. M. Gandini Wheeler‐Kingshott, Paul S. Tofts, Declan Chard and Massimo Filippi. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact